Donertas, B. Et Al. 2018. Agmatine co-treatment attenuates allodynia and structural abnormalities in cisplatin-induced neuropathy in rats. FUNDAMENTAL & CLINICAL PHARMACOLOGY , vol.32 , 288-296.

Donertas, B., Çengelli Ünel, Ç., Aydın, Ş., Ulupınar, E., Özatik, O., Kaygısız, B., ... Yıldırım, E.(2018). Agmatine co-treatment attenuates allodynia and structural abnormalities in cisplatin-induced neuropathy in rats. FUNDAMENTAL & CLINICAL PHARMACOLOGY , vol.32, 288-296.

Donertas, Basak Et Al. "Agmatine co-treatment attenuates allodynia and structural abnormalities in cisplatin-induced neuropathy in rats," FUNDAMENTAL & CLINICAL PHARMACOLOGY , vol.32, 288-296, 2018

Donertas, Basak Et Al. "Agmatine co-treatment attenuates allodynia and structural abnormalities in cisplatin-induced neuropathy in rats." FUNDAMENTAL & CLINICAL PHARMACOLOGY , vol.32, pp.288-296, 2018

Donertas, B. Et Al. (2018) . "Agmatine co-treatment attenuates allodynia and structural abnormalities in cisplatin-induced neuropathy in rats." FUNDAMENTAL & CLINICAL PHARMACOLOGY , vol.32, pp.288-296.

@article{article, author={Basak Donertas Et Al. }, title={Agmatine co-treatment attenuates allodynia and structural abnormalities in cisplatin-induced neuropathy in rats}, journal={FUNDAMENTAL & CLINICAL PHARMACOLOGY}, year=2018, pages={288-296} }